PDT Partners LLC acquired a new position in Stepan Company (NYSE:SCL - Free Report) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 48,126 shares of the basic materials company's stock, valued at approximately $2,682,000. PDT Partners LLC owned approximately 0.21% of Stepan at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Deprince Race & Zollo Inc. increased its position in Stepan by 5.2% during the 1st quarter. Deprince Race & Zollo Inc. now owns 947,452 shares of the basic materials company's stock valued at $47,354,000 after buying an additional 47,075 shares in the last quarter. Empowered Funds LLC boosted its holdings in Stepan by 124.8% in the first quarter. Empowered Funds LLC now owns 174,376 shares of the basic materials company's stock worth $8,715,000 after acquiring an additional 96,823 shares in the last quarter. North Star Investment Management Corp. bought a new stake in Stepan in the first quarter worth $850,000. First Trust Advisors LP grew its stake in shares of Stepan by 11.2% in the first quarter. First Trust Advisors LP now owns 94,340 shares of the basic materials company's stock worth $4,715,000 after acquiring an additional 9,534 shares during the last quarter. Finally, Dean Capital Management grew its stake in shares of Stepan by 96.4% in the first quarter. Dean Capital Management now owns 57,248 shares of the basic materials company's stock worth $2,861,000 after acquiring an additional 28,104 shares during the last quarter. Hedge funds and other institutional investors own 82.70% of the company's stock.
Stepan Stock Up 0.9%
Shares of Stepan stock opened at $62.60 on Thursday. Stepan Company has a twelve month low of $41.82 and a twelve month high of $68.00. The company has a quick ratio of 0.77, a current ratio of 1.15 and a debt-to-equity ratio of 0.20. The company's 50 day moving average is $59.69 and its 200 day moving average is $54.99. The company has a market cap of $1.42 billion, a price-to-earnings ratio of -521.67 and a beta of 0.94.
Stepan (NYSE:SCL - Get Free Report) last posted its earnings results on Wednesday, July 29th. The basic materials company reported $1.18 EPS for the quarter, topping analysts' consensus estimates of $0.61 by $0.57. The business had revenue of $684.11 million during the quarter, compared to the consensus estimate of $635.85 million. Stepan had a negative net margin of 0.11% and a positive return on equity of 3.90%. The firm's revenue was up 15.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.52 EPS. Research analysts anticipate that Stepan Company will post 2.69 EPS for the current year.
Stepan Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be issued a $0.395 dividend. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $1.58 annualized dividend and a dividend yield of 2.5%. Stepan's payout ratio is presently -1,316.67%.
Analyst Ratings Changes
Several equities analysts have recently issued reports on SCL shares. Seaport Research Partners reaffirmed a "buy" rating and issued a $85.00 price target on shares of Stepan in a research report on Friday, August 7th. Wall Street Zen raised shares of Stepan from a "hold" rating to a "buy" rating in a research report on Saturday, August 8th. Weiss Ratings upgraded shares of Stepan from a "sell (d)" rating to a "sell (d+)" rating in a research note on Wednesday, July 29th. Finally, Zacks Research raised shares of Stepan from a "strong sell" rating to a "hold" rating in a report on Monday, July 6th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Reduce".
Get Our Latest Research Report on Stepan
Stepan Company Profile
(
Free Report)
Stepan Company is a global manufacturer of specialty and intermediate chemicals, primarily known for its development and production of surfactants and related specialty products. The company's portfolio includes a wide range of ingredients used to enhance the performance of consumer and industrial formulations, such as emulsifiers, foam control agents, odor control agents, antimicrobial products and performance additives. These products are integral components in cleaning solutions, personal care items, agrochemical formulations, coatings, oilfield treatments and polymer systems.
Serving a diverse set of end-markets, Stepan's offerings address both consumer-facing and industrial applications.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Stepan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stepan wasn't on the list.
While Stepan currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.